COVID-19相关心律失常与自主神经功能障碍:美国心脏协会科学声明
该美国心脏协会科学声明综述了COVID-19感染期间及恢复期心律失常与自主神经功能障碍的流行病学、病理生理、临床表现和管理证据。声明指出心律失常表现从良性到危及生命不等,COVID-19及疫苗相关心肌炎症和自主神经紊乱值得关注,并提供了基于证据的实践指导。
要点
- COVID-19感染和恢复期常见心律失常,表现谱从良性到致命。
- COVID-19及疫苗相关心肌炎症和自主神经紊乱仍是关注点。
- 大流行转为地方性流行后仍需警惕心律失常和自主神经功能障碍。
核心结论
- COVID-19相关心律失常和自主神经功能障碍在感染及恢复期均常见,需持续警惕。
研究设计与样本
- 美国心脏协会科学声明,基于现有证据综述并提出共识指导。
主要发现
- 心律失常表现涵盖良性至危及生命,病理生理机制多样。
- COVID-19和疫苗相关心肌炎症及自主神经紊乱仍受关注。
临床怎么用
- 对COVID-19感染及恢复期患者应警惕心律失常和自主神经功能障碍。
局限性
- 声明基于现有证据共识,未提供具体数值或阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Arrhythmic manifestations span the spectrum of innocuous and benign to life-threatening and deadly. Various pathophysiological mechanisms have been proposed. Debate continues on the impact of incident and exacerbated arrhythmias on the acute and chronic (recovery) phase of the illness. COVID-19 and COVID-19 vaccine-associated myocardial inflammation and autonomic disruption remain concerns. As the pandemic has transformed to an endemic, with discovery of new SARS-CoV-2 variants, updated vaccines, and potent antiviral drugs, vigilance for COVID-19-associated arrhythmic and dysautonomic manifestations remains. The objective of this American Heart Association scientific statement is to review the available evidence on the epidemiology, pathophysiology, clinical presentation, and management of cardiac arrhythmias and autonomic dysfunction in patients infected with and recovering from COVID-19 and to provide evidence-based guidance. The writing committee's consensus on implications for clinical practice, gaps in knowledge, and directions for future research are highlighted.
引用
- Gopinathannair R, Olshansky B, Chung MK, et al. Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 39397661. doi:10.1161/CIR.0000000000001290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。